Aug 11, 2026
Medication Adherence Isn’t a Patient Problem; It's a Data Problem
Medication adherence fails first in the data, then in the patient. When sponsors, digital innovators, and pharma executives treat adherence primarily as a behavioral or engagement issue, they end up fighting symptoms instead of fixing signals. There is an opportunity to re‑architect adherence as a data problem: how we capture, standardize, analyze, and act on medication‑taking behavior across trials and commercial use. That’s the lens AICure brings to the table, and it’s where AI‑driven, patient‑level behavioral data can change both clinical outcomes and drug performance.